NEW YORK, May 2 – Motorola has tested its eSensor DNA detection system at a UCLA hospital-based genetic testing laboratory to study disease-associated genetic variations, the company said Wednesday.

Wayne Grody, the director of the UCLA molecular genetics laboratory, used eSensor to detect genetic mutations associated with hereditary hemochromatosis—the most common single mutation-based genetic disease. The results showed that the eSensor worked to verify genetic diseases in all of the 33 patients tested. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.